US2009124777A1PendingUtilityA1
Compositions for Delivering Nucleic Acids to Cells
Est. expiryMay 24, 2022(expired)· nominal 20-yr term from priority
C12N 15/87A61K 48/0041
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Cyclic amidinium containing compounds and their methods of preparation are described. Compositions containing these compounds facilitate delivery of biologically active polymers to cells in vitro and in vivo.
Claims
exact text as granted — not AI-modified1 . A composition for delivering a polynucleotide to a cell comprising: a cationic poly(cyclic amidinium)-containing compound capable of condensing nucleic acid and the polynucleotide.
2 . The composition of claim 2 wherein the poly cyclic amidinium consists of a poly 1,3-piperazinium.
3 . The composition of claim 2 wherein the polynucleotide is selected from the group consists of: DNA, RNA, and siRNA.
4 . The composition of claim 2 wherein the poly cyclic amidinium is selected from the group consisting of: partially acylated polyethylenimine, partially acylated polyallylamine, and partially acylated polyvinylamine.
5 . The composition of claim 2 wherein the poly cyclic amidinium consists of a poly 1,3-nitrogen-8-membered heterocyclic ring.
6 . The composition of claim 5 wherein the polynucleotide is selected from the group consists of: DNA, RNA, and siRNA.
7 . The composition of claim 2 wherein the poly cyclic amidinium is selected from the group consisting of: partially acylated polyethylenimine, partially acylated polyallylamine, and partially acylated polyvinylamine.
8 . The composition of claim 1 wherein the cell consists of an in vivo cell.
9 . The composition of claim 11 wherein the in vivo cell consists of a lung cell.
10 . The composition of claim 11 wherein the in vivo cell consists of a liver cell.
11 . The composition of claim 13 wherein the liver cell consists of a hepatocyte.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.